Phytohealth Corp (4108)

Currency in TWD
11.20
+0.25(+2.28%)
Closed·
Advertisement
4108 is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
11.0011.25
52 wk Range
10.9017.90
Key Statistics
Bid/Ask
11.10 / 11.20
Prev. Close
10.95
Open
11.1
Day's Range
11-11.25
52 wk Range
10.9-17.9
Volume
205.1K
Average Volume (3m)
270.61K
1-Year Change
-12.5%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
4108 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Liquid assets exceed short term obligations

Phytohealth Corp News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Buy

Earnings

Latest Release
04/08/2026
EPS / Forecast
-0.03 / --
Revenue / Forecast
35.91M / --
EPS Revisions
Last 90 days

Compare 4108 to Peers and Sector

Metrics to compare
4108
Peers
Sector
Relationship
P/E Ratio
−51.3x−4.6x−0.3x
PEG Ratio
−1.480.170.00
Price/Book
1.1x1.4x2.6x
Price / LTM Sales
15.5x1.8x3.1x
Upside (Analyst Target)
-13.9%48.3%
Fair Value Upside
Unlock17.1%6.7%Unlock

PhytoHealth Corporation researches, develops, manufactures, and sells medicines, cosmetics, Class B medicines, complementary foods, and other related products in Taiwan. It operates in three segments: Medicines and Health Food, Medical Diagnosis, and Precision Medical Equipment and Instruments. The Medicines and Health Food segment manufactures and sells Chinese medicine materials and new drugs. The Medical Diagnosis segment develops and sells smart medical imaging diagnostic products. The Precision Medical Equipment and Instruments segment engages in the research and development, manufacturing, and sale of ultrasound probes and analysis systems. Its products under development include PHN031, which has completed Phase II clinical trials for the treatment of osteoporosis, and PHN033, which has completed Phase II clinical trials for the treatment of diabetic nephropathy. The company is also developing PHN016, which is in Phase II clinical trials for the treatment of cancer, and PHN017, which is in Phase I trials for the treatment of severe infection-induced cytokine storm. In addition, it offers PG2 Lyophilized Injection for the treatment of cancer-related fatigue and capsules for acute moderate to severe pain. PhytoHealth Corporation was incorporated in 1998 and is based in Taipei, Taiwan.

Employees
84
Market
Taiwan

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.28M0.65%14.04M
Other Institutional Investors
41.60M20.95%455.54M
Public Companies & Retail Investors
155.73M78.41%1.71B
Total
198.62M100.00%2.17B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Maywufa Company Ltd.19.50%38,730,698424,101
International CSRC Investment Holdings Co., Ltd.0.90%1,793,58419,640

FAQ

What Is the Phytohealth (Taiwan: 4108) Share Price Today?

The Phytohealth stock price today is 11.20 TWD.

What Stock Exchange Does Phytohealth (4108) Trade On?

Phytohealth is listed and trades on the Taiwan Stock Exchange.

What Is the Ticker (Stock Symbol) for Phytohealth?

The stock symbol (also called a 'ticker') for Phytohealth is "4108."

What Is the Current Phytohealth Market Capitalisation?

As of today, Phytohealth (Taiwan: 4108) market cap is 2.22B TWD.

What Is Phytohealth's (4108) Earnings Per Share (TTM)?

The Phytohealth EPS is currently -0.22 (Trailing Twelve Months).

Is 4108 a Buy or Sell From a Technical Analyst Perspective?

Based on today's Phytohealth moving averages and other technical indicators, the daily buy/sell signal for 4108 stock is Strong Sell.

How Many Times Has Phytohealth Stock Split?

Phytohealth has split 4 times. (See the 4108 stock split history page for full effective split date and price information.)

How Many Employees Does Phytohealth Have?

Phytohealth has 84 employees, based on their latest Companies House report.

What is the current trading status of Phytohealth (Taiwan: 4108)?

As of 13/08/2026, Phytohealth (4108) is trading at a share price of 11.20 TWD, with a previous close of 10.95 TWD. The stock has fluctuated within a day range of 11.00 TWD to 11.25 TWD, while its 52-week range spans from 10.90 TWD to 17.90 TWD.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.